The purpose of this study is to evaluate the effect of prebiotic or synbiotic supplementation on inflammatory response and indicators of nutritional status in patients with morbid obesity. Study hypothesis: Supplementation of 12 g/day of fructooligosaccharides (prebiotic) or 12 g/day of fructooligosaccharides + strains of lactobacilli and bifidobacteria (synbiotic) during 30 days promotes reduction of plasma/serum levels of acute phase proteins, cytokines, metabolic and anthropometric parameters in individuals with BMI ≥ 40kg/m².
The purpose of this study is to evaluate the effect of prebiotic or synbiotic supplementation on inflammatory response and indicators of nutritional status in patients with morbid obesity. Adult individuals of both sexes with morbid obesity (body mass index ≥ 40 kg/m²) will be invited to participate in this randomized, placebo-controlled, triple-blind study. The participants will be divided into three groups: G1 - control group (placebo), G2 - prebiotic group and G3 - synbiotic group. The study will consist of four experimental time points: M0 - baseline and start of supplementation; M1 - after fifteen days of the first outpatient visit and fifteen days after the start of supplementation with prebiotic, synbiotic or placebo; M2 - after thirty days from the first outpatient visit and end of supplementation with prebiotic, synbiotic and placebo; and M3 - time after sixty days from the first outpatient visit. At all time points the inflammatory response will be assessed by determination of plasma cytokines (IL-1, IL-6, IL-10, TNF) and acute phase proteins (c-reactive protein and albumin), besides the evaluation of laboratory and anthropometric indicators of nutritional status. The primary endpoint will be the reduction in concentrations of inflammatory markers (cytokines and acute phase proteins). Investigators expect to contribute with new information in this field of knowledge, which may facilitate the clinical application of these results.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
22
Polydoro Ernani de São Thiago University Hospital
Florianópolis, Santa Catarina, Brazil
C-reactive protein
Serum C-reactive protein concentrations (mg/L)
Time frame: 2 months
Cytokines
Plasma IL-1, IL-6, IL-8, IL-10, IL-12p70 and TNF-alpha concentrations (pg/mL)
Time frame: 2 months
Triglycerides
Serum concentrations of triglycerides (mg/dL)
Time frame: 2 months
Total cholesterol
Serum concentrations of total cholesterol (mg/dL)
Time frame: 2 months
LDL-c
Serum concentrations of LDL-cholesterol (mg/dL)
Time frame: 2 months
HDL-c
Serum concentrations of HDL-cholesterol (mg/dL)
Time frame: 2 months
Blood glucose
Blood glucose concentrations (mg/dL)
Time frame: 2 months
Glycated hemoglobin
Blood concentrations of glycated hemoglobin (%)
Time frame: 2 months
Growth hormone
Serum concentrations of Growth hormone (ng/mL)
Time frame: 2 months
Fasting insulin
Serum concentrations of insulin (IU/mL)
Time frame: 2 months
Calcium
Serum concentrations of calcium (mg/dL)
Time frame: 2 months
Iron
Serum concentrations of iron (mg/dL)
Time frame: 2 months
Sodium
Serum concentrations of sodium (mEq/L)
Time frame: 2 months
Potassium
Serum concentrations of potassium (mEq/L)
Time frame: 2 months
Phosphorus
Serum concentrations of phosphorus(mg/dL)
Time frame: 2 months
Folic acid
Serum concentrations of folic acid (ng/mL)
Time frame: 2 months
Vitamin B12
Serum concentrations of vitamin B12 (pg/mL)
Time frame: 2 months
Vitamin D
Serum concentrations of vitamin D (ng/dL)
Time frame: 2 months
Body weight
Body weight (kg)
Time frame: 2 months
Waist circumference
Waist circumference (cm)
Time frame: 2 months
Body mass index
Body mass index (kg/m²)
Time frame: 2 months
Brain-derived neurotrophic factor (BDNF)
Plasma Brain-derived neurotrophic factor (ng or pg/mL)
Time frame: 2 months
Cortisol
Plasma cortisol (ug/dL)
Time frame: 2 months
Leptin
Plasma leptin (ng/mL)
Time frame: 2 months
Ghrelin
Plasma ghrelin (pg/mL)
Time frame: 2 months
Adrenocorticotropic Hormone (ACTH)
Plasma Adrenocorticotropic Hormone (pg/mL)
Time frame: 2 months
Hepcidin
Hepcidin (ng/mL)
Time frame: 2 months
Parathormone (PTH)
Parathormone (ng/mL)
Time frame: 2 months
Thyroid-Stimulating Hormone (TSH)
Thyroid-Stimulating Hormone (µIU/mL)
Time frame: 2 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.